Market revenue in 2023 | USD 10,019.7 million |
Market revenue in 2030 | USD 14,606.6 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | Consulting |
Fastest growing segment | Training & Education |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education |
Key market players worldwide | PAREXEL, IQVIA Holdings Inc, Heidelberg Materials AG, Labcorp Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Syneos Health, Lonza Group Ltd, Catalent Inc, Samsung BioLogics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology and pharmaceutical services outsourcing market will help companies and investors design strategic landscapes.
Consulting was the largest segment with a revenue share of 48.82% in 2023. Horizon Databook has segmented the Europe biotechnology and pharmaceutical services outsourcing market based on consulting, regulatory affairs, product design & development, auditing and assessment, product maintenance, training & education covering the revenue growth of each sub-segment from 2018 to 2030.
Europe has a robust biotechnology & pharmaceutical sector with numerous drug discoveries, development, and manufacturing companies. The increasing trend of outsourcing services to European countries is expected to boost the market in this region.
In Europe, small- & mid-sized biotechnology & pharmaceutical companies increasingly need regulatory services and product design departments.
Hence, companies often prefer to hire consultants or legal representatives to guide them through the various stages of the product lifecycle to overcome the regulatory hurdles and expand access to rare & orphan medications in Europe and across the globe.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biotechnology and pharmaceutical services outsourcing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe biotechnology and pharmaceutical services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account